Journal of Cystic Fibrosis
Volume 9, Issue 2 , Pages 104-109 , March 2010

Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres

Received 2 October 2009 ,Revised 26 November 2009 ,Accepted 30 November 2009.

References 

  1. Gould FK, Brindle R, Chadwick PR, Fraise AP, Hill SP, et al. Guideline for the prophylaxis and treatment of methicillin resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrobial Chemother. 2009;63(5):849–861
  2. Consensus report. MRSA in cystic fibrosis. J Hosp Infect. 1998;40:179–191
  3. Boxerbaum B, Jacobs MR, Cechner RL. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol. 1988;4(3):159–163Erratum in: Pediatr Pulmonol 1988;5(1):66
  4. Sawicki GS, Rasouliyan L, Pasta DJ, Regelmann WE, Wagener JS, Waltz DA, et al. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol. 2008;43(11):1117–1123
  5. Cystic Fibrosis Foundation. Patient Registry 2007 annual report. Bethesda, MD: Cystic Fibrosis Foundation; 2008;
  6. Cystic Fibrosis Foundation. Patient Registry 2002 annual report. Bethesda MD: Cystic Fibrosis Foundation; 2003;
  7. UK Cystic Fibrosis Trust Infection Control Working Group. Methicillin resistant Staphylococcus aureus (MRSA). 2008. UK CF Trust. Ref Type: Report.
  8. Givney R, Vickery A, Holliday A, Pegler M, Benn R. Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit. J Hosp Infect. 1997;35(1):27–36
  9. Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, et al. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol. 2007;42(6):513–518
  10. Miall LS, McGinley NT, Brownlee KG, Conway SP. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis. Arch Dis Child. 2001;84(2):160–162
  11. Thomas SR, Gyi KM, Gaya H, Hodson ME. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect. 1998;40(3):203–209
  12. Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med. 2008;178(8):814–821
  13. Macfarlane M, Leavy A, McCaughan J, Fair R, Reid AJ. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol. J Hosp Infect. 2007;65(3):231–236
  14. Solís A, Brown D, Hughes J, Van Saene HK, Heaf DP. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: an eradication protocol. Pediatr Pulmonol. 2003;36(3):189–195
  15. Máiz L, Cantón R, Mir N, Baquero F, Escobar H. Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. Pediatr Pulmonol. 1998;26(4):287–289
  16. Serisier DJ, Jones G, Carroll M. Eradication of pulmonary methicillin-resistant Staphylococcus aureus (MRSA) in cystic fibrosis with linezolid. J Cyst Fibros. 2004;3(1):61
  17. Garske LA, Kidd TJ, Gan R, Bunting JP, Franks CA, Coulter C, et al. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection. J Hosp Infect. 2004;56(3):208–214
  18. Ferrin M, Zuckerman JB, Meagher A, Blumberg EA. Successful treatment of methicillin-resistant Staphylococcus aureus pulmonary infection with linezolid in a patient with cystic fibrosis. Pediatr Pulmonol. 2002;33(3):221–223
  19. Kappler M, Felicke M, Schweiger-Kabesch , Schroter C, Liese J, Ripper J, et al. Eradication of methicillin resistant Staphylococcus aureus in cystic fibrosis. J Cyst Fibros. 2009;8(Suppl 2):abstract 170
  20. Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43:2384–2390
  21. Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet. 2001;358:557–558
  22. McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet. 2001;358:558–560
  23. Saiman L, Seigel J and the Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient to patient transmission. Infect Control Hosp Epidemiol. 2003;24(Suppl 5):S6–S52
  24. Zhou J, Garber E, Saiman L. Survey of infection control policies for patients with cystic fibrosis in the United States. Am J Infect Control. 2008;36(3):220–222
  25. Molina A, Del Campo R, Máiz L, Morosini MI, Lamas A, Baquero F, et al. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. J Antimicrob Chemother. 2008;62(5):961–967
  26. Kidd TJ, Coulter C, Bell SC. Epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from adult patients with cystic fibrosis. Infect Control Hosp Epidemiol. 2006;27(2):201–203
  27. Glikman D, Siegel JD, David MZ, Okoro NM, Boyle-Vavra S, Dowell ML, et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S. aureus. Chest. 2008;133(6):1381–1387
  28. Downey DG, Kidd TJ, Coulter C, Bell SC. MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?. J Cyst Fibros. 2005;4(3):205–207
  29. Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM, Buller RS, et al. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest. Jun 2007;131(6):1718–1725

☆ The authors can confirm that this was an unfunded study.

PII: S1569-1993(09)00156-8

doi: 10.1016/j.jcf.2009.11.009

Journal of Cystic Fibrosis
Volume 9, Issue 2 , Pages 104-109 , March 2010

Article Tools

* Image Usage & Resolution